[{"id":"8e56dd2a-34ed-4f0a-9d6b-9660a9737c00","acronym":"BVAC-C-P1","url":"https://clinicaltrials.gov/study/NCT02866006","created_at":"2021-01-29T07:13:02.742Z","updated_at":"2024-07-02T16:36:02.606Z","phase":"Phase 1/2","brief_title":"Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer","source_id_and_acronym":"NCT02866006 - BVAC-C-P1","lead_sponsor":"Cellid Co., Ltd.","biomarkers":" CD4","pipe":"","alterations":" ","tags":["CD4"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e topotecan • BVAC-C"],"overall_status":"Completed","enrollment":" Enrollment 32","initiation":"Initiation: 10/01/2016","start_date":" 10/01/2016","primary_txt":" Primary completion: 12/01/2021","primary_completion_date":" 12/01/2021","study_txt":" Completion: 06/01/2022","study_completion_date":" 06/01/2022","last_update_posted":"2022-10-12"}]